Biofarm S.A.

BVB:BIO Stock Report

Market Cap: RON 1.3b

Biofarm Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Catalin Vicol

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.7yrs
CEO ownershipn/a
Management average tenure7.2yrs
Board average tenure8.5yrs

Recent management updates

Recent updates

Analysis Article • Apr 01

Biofarm (BVB:BIO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Despite posting some strong earnings, the market for Biofarm S.A.'s ( BVB:BIO ) stock hasn't moved much. We did some...
Analysis Article • Mar 18

Is Biofarm S.A.'s (BVB:BIO) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Biofarm's (BVB:BIO) stock is up by a considerable 40% over the past three months. Given that the market rewards strong...
Analysis Article • Feb 18

Is There More To The Story Than Biofarm's (BVB:BIO) Earnings Growth?

Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...
Analysis Article • Jan 23

Shareholders Of Biofarm (BVB:BIO) Must Be Happy With Their 140% Total Return

When we invest, we're generally looking for stocks that outperform the market average. And the truth is, you can make...
Analysis Article • Dec 25

A Look At The Intrinsic Value Of Biofarm S.A. (BVB:BIO)

Today we will run through one way of estimating the intrinsic value of Biofarm S.A. ( BVB:BIO ) by taking the expected...
Analysis Article • Dec 03

Could The Biofarm S.A. (BVB:BIO) Ownership Structure Tell Us Something Useful?

The big shareholder groups in Biofarm S.A. ( BVB:BIO ) have power over the company. Institutions often own shares in...

CEO

Catalin Vicol (52 yo)

7.7yrs
Tenure

Mr. Catalin Constantin Vicol is Non-Independent Executive Director of Biofarm S.A. from November 15, 2018. He was GM of Biofarm S.A. from November 15, 2018 to 2026 and serves as its chief Executive Officer...

Leadership Team

NamePositionTenureCompensationOwnership
Catalin Vicol
CEO & Non-Independent Executive Director7.7yrsno datano data
Mihai Zoescu
Chief Financial Officer5.5yrsno datano data
Mirel Florica
Chief Operations Officer2.5yrsno datano data
Matei Monica Dobrisan
Chief Accountant10.2yrsno datano data
Gheorghe Pacea
Technical Manager2.8yrsno datano data
Valentin Constantin
Legal & Investor Relations Manager6.9yrsno datano data
Ioana Goranescu
Marketing Manager7.5yrsno datano data
Mariana Bogde
Human Resource Manager8.3yrsno datano data
Rachid El Lakis
Deputy Chief Executive Officer1.3yrsno datano data
Diana Vizitiu
Controlling & Reporting Department Manager7.8yrsno datano data
7.2yrs
Average Tenure
47yo
Average Age

Experienced Management: BIO's management team is seasoned and experienced (7.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Catalin Vicol
CEO & Non-Independent Executive Director8.5yrsno datano data
Bogdan Dragoi
Non-Independent Non-Executive Director10.6yrsno datano data
Andrei Hrebenciuc
Independent Chairman of the Board12.7yrsno datano data
Sari Lakis
Non-Independent Non-Executive Directorless than a yearno datano data
Stefan Dumitru
Non Executive Non independent Directorless than a yearno datano data
8.5yrs
Average Tenure
46yo
Average Age

Experienced Board: BIO's board of directors are considered experienced (8.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/09 18:32
End of Day Share Price 2026/07/09 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biofarm S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vladimira UrbankovaErste Group Bank AG
Raluca FloreaErste Group Bank AG